Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck
- 16 November 2006
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 29 (5), 472-478
- https://doi.org/10.1002/hed.20533
Abstract
Background. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) represent 2 clinically important subtypes of head and neck cancer. Our objective was to characterize and compare cytokine profiles in the systemic circulation of patients with SCC and ACC. Methods. Multiplex analysis of 10 different cytokines (interleukin [IL]-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor [GM-CSF], interferon [IFN]-γ, and tumor necrosis factor [TNF]-α) in the serum of patients with SCC (n = 20) and ACC (n = 20) and healthy controls (n = 20) was performed using the Luminex fluorescent-bead technology. Results. Patients with SCC as well as patients with ACC showed an altered cytokine profile compared with healthy individuals. In patients with SCC, significantly elevated serum levels of the proinflammatory cytokines, IL-6 and IL-8, were observed. In patients with ACC, IL-8 serum levels were significantly elevated, and IL-6 serum levels were only increased in a subset of patients. Conclusions. A similar serum cytokine profile, with the predominance of proinflammatory cytokines, was observed in patients with SCC and ACC. The newly defined cytokine profile in ACC patients may form the basis for future investigations to explore the role of cytokines in ACC tumor progression and their potential value as predictive biomarkers. © 2006 Wiley Periodicals, Inc. Head Neck, 2007Keywords
This publication has 32 references indexed in Scilit:
- Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapyInternational Journal of Cancer, 2005
- A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinomaHead & Neck, 2005
- Multiplexed Analysis of Serum Cytokines as Biomarkers in Squamous Cell Carcinoma of the Head and Neck PatientsThe Laryngoscope, 2005
- Immunobiology of head and neck cancerCancer and Metastasis Reviews, 2005
- An inflammatory linkNature, 2004
- Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neckCytokine, 2004
- Clinical significance of interleukin‐6 and interleukin‐6 receptor expressions in oral squamous cell carcinomaHead & Neck, 2002
- Expression of interleukin-8 detected byin situ hybridization correlates with worse prognosis in primary cutaneous melanomaThe Journal of Pathology, 1999
- Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancerInternational Journal of Cancer, 1996
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994